Literature DB >> 12009568

Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.

R Döffinger1, S Dupuis, C Picard, C Fieschi, J Feinberg, G Barcenas-Morales, J-L Casanova.   

Abstract

In the last 6 years, considerable advances have been made in the molecular analysis of a rare clinical syndrome: Mendelian susceptibility to mycobacterial disease (MSMD). Infection with poorly virulent environmental non-tuberculous mycobacteria (NTM) or vaccination with bacillus Calmette-Guerin (BCG) may cause disseminating and even fatal disease in individuals suffering from this syndrome. Mutations in five genes (IFNGR1, IFNGR2, STAT1, IL12B and IL12RB1) have been shown to be responsible for MSMD and further allelic heterogeneity accounts for the existence of nine distinct inherited disorders. All of these disorders are caused by impaired IFNgamma-mediated immunity. These results have important medical and biological implications. In this report, we update the disease-causing mutations reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009568     DOI: 10.1016/s0161-5890(02)00017-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

1.  Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.

Authors:  Brian Becknell; Tiffany L Hughes; Aharon G Freud; Bradley W Blaser; Jianhua Yu; Rossana Trotta; Hsiaoyin C Mao; Marie L Caligiuri de Jesús; Mohamad Alghothani; Don M Benson; Amy Lehman; David Jarjoura; Danilo Perrotti; Michael D Bates; Michael A Caligiuri
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

2.  Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.

Authors:  Virginia Davids; Willem Hanekom; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory Hussey; Ronel Sheperd; Lesley Workman; Jorge Soler; Rose Ann Murray; Stanley R Ress; Gilla Kaplan
Journal:  Clin Vaccine Immunol       Date:  2006-12-20

Review 3.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 4.  Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.

Authors:  T Kampitak; G Suwanpimolkul; S Browne; C Suankratay
Journal:  Infection       Date:  2010-12-03       Impact factor: 3.553

Review 5.  Host defenses against bacterial lower respiratory tract infection.

Authors:  Taylor Eddens; Jay K Kolls
Journal:  Curr Opin Immunol       Date:  2012-07-25       Impact factor: 7.486

Review 6.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Decreased cytokine production in patients with nontuberculous mycobacterial lung disease.

Authors:  Yong Soo Kwon; Eun Joo Kim; Shin-Hye Lee; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Won-Jung Koh
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

Review 8.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

9.  Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs.

Authors:  Loukia-Maria Mitsos; Lon R Cardon; Lynn Ryan; Ronald LaCourse; Robert J North; Philippe Gros
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

10.  Ustekinumab in the therapy of chronic plaque psoriasis.

Authors:  Jenna L O'Neill; Robert E Kalb
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.